RocketVax
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
RocketVax has raised €6.7M across 1 funding round from 3 investors, most recently a Series A round in Aug 2021. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandrocketvax.com ↗
Total raised
€6.7M
€6,708,283
Funding rounds
1
Investors
3
distinct backers
Active since
2021-08
latest 2021-08
Funding by year
EUR raised per yearRocketVax — funding by year — interactive chart.
Data table
| RocketVax — funding by year | |
|---|---|
| 2021 | €6.7M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-05 | Series A | €6.7M | Canton of Basel-Stadt,Innosuisse,University Hospital Basel | View deal → |
Related news
- RocketVax raises CHF 7.2 million to advance clinical studies for its COVID 19 vaccinestartupticker.ch · 2021-08
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData